Methods of treatment using anti-erbb antibody-maytansinoid conjugates

Methods of treatment using anti-erbb antibody-maytansinoid conjugates

  • CN 101,518,653 A
  • Filed: 06/23/2000
  • Published: 09/02/2009
  • Est. Priority Date: 06/25/1999
  • Status: Abandoned Application
First Claim
Patent Images

1. antibody-drug conjugates, wherein to the lysine of described anti-ErbB antibody or the covalently bound class maytansine of covalency joint of cysteine residues, described class maytansine is selected from maytansine, the smooth alcohol ester of U.S. smooth pure and mild U.S. to anti-ErbB antibody through covalently bound.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×